Repeated THC Shortened Movement Suppression Without Reducing Its Peak in Rats

A 1977 rat study found tolerance to the duration of THC-related movement suppression while peak suppression remained similar. A shorter effect and a weaker maximum effect are not equivalent descriptions of tolerance.

The time course exposed the difference

After one injection, movement suppression was greatest for several hours and resolved later. After nine injections, the maximum suppression was similar, but the response ended earlier. A single measurement near the peak could therefore have missed the adaptation detected by following the full time course.

Brain distribution supplied a proposed explanation

Subcellular analyses suggested a faster shift from THC and 11-hydroxy-THC toward more polar metabolites in tolerant brains. The authors favored this interpretation over faster elimination of the parent cannabinoids or reduced brain sensitivity. The tissue pattern was evidence for that explanation, not a complete measurement of every functional mechanism.

Metabolite findings are matrix-specific

These were brain-related distribution measurements, not a modern whole-blood impairment threshold. Different chemical species should not be combined into an undifferentiated THC concentration. Nor can an animal effect duration be translated directly into a waiting period for people.

The experiment shows why a tolerance claim needs a defined feature of the response: peak intensity, potency, duration or another measure. Its historical injected regimen does not establish a human safe interval or show that all cannabis effects shorten in parallel.

Related: interpreting cannabis tolerance claims.

Research cited

Magour S; Coper H; Fähndrich C. Is tolerance to delta-9-THC cellular or metabolic? The subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats. Psychopharmacology (1977). doi:10.1007/BF00431730. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

A review published in 2020 graded psychiatric evidence from studies of CBD and CBD-containing nabiximols. Its recommendation labels should not be quoted as though every underlying intervention was purified CBD or every study was randomized. The included designs ranged widely The review identified 23 relevant studies spanning case reports, case…

Spread the love

Read Article: A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

A 2021 ocular CBD review brought together in-vitro and in-vivo research, proposed molecular targets and possible therapeutic applications. This evidence maps a development pathway; it does not establish that CBD products are effective eye treatments. The experimental system belongs in the conclusion A cellular result can identify a target or…

Spread the love

Read Article: CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

A 2021 review evaluated CBD research on reinforcing, motivational and withdrawal-related drug effects. These outcomes can inform substance-use-disorder research, but an improvement in one cannot establish successful treatment across all of them. The source combined preclinical and clinical reports The review covered alcohol, opioids, cannabinoids, nicotine and psychostimulants. An animal…

Spread the love

Read Article: CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us